Voyager Therapeutics
VYGR
VYGR
132 hedge funds and large institutions have $331M invested in Voyager Therapeutics in 2024 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 56 increasing their positions, 29 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+25
Holders Change %
+23.36%
% of All Funds
1.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
56
Reduced
29
Closed
7
Calls
$579K
Puts
$700K
Net Calls
-$121K
Net Calls Change
-$307K
Top Buyers
| 1 |
BlackRock
New York
|
+$16.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.5M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$9.31M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.54M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$5.59M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.9M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.6M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.16M |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$878K |
| 5 |
II
Inspire Investing
Meridian,
Idaho
|
-$802K |
